Human Colon Cancer Tissue Lysates
Pricing |
Normal Lysates: $125/100 ug |
Tumor Lysates: $175/100 ug |
Nor./Tum. set: $270.00 (10% off) |
Discounts |
2-8 Vials 10% |
9-20 Vials 15% |
>20 Vials 20% |
Introduction:
Histologic types of colon cancer include the following:
Adenocarcinoma (most colon cancers); Mucinous (colloid) adenocarcinoma, Signet ring adenocarcinoma.
Scirrhous tumors.
Neuroendocrine. Tumors with neuroendocrine differentiation typically have a poorer prognosis than pure adenocarcinoma variants.
Human Colon Cancer Tissue Lysates | ||||||
Catalog Number |
Diagnosis |
Grade |
Stage |
TNM |
Sex |
Age |
Adenocarcinoma |
2 |
n/a |
n/a |
F |
70 |
|
Adenocarcinoma |
2 |
I |
T2N0M0 |
M |
77 |
|
Adenocarcinoma |
1 |
I |
T2N0M0 |
M |
75 |
|
Adenocarcinoma |
1 |
I |
T2N0M0 |
M |
25 |
|
Adenocarcinoma |
1 |
II |
T3N0M0 |
M |
44 |
|
Adenocarcinoma |
2 |
II |
T3N0M0 |
M |
49 |
|
Adenocarcinoma |
2 |
II |
T3N0M0 |
M |
41 |
|
Adenocarcinoma |
3 |
II |
T3N0M0 |
M |
52 |
|
Adenocarcinoma |
3 |
II |
T4NxM0 |
M |
67 |
|
Adenocarcinoma |
n/a |
IIB |
n/a |
M |
46 |
|
Mucinous Adenocarcinoma |
n/a |
III |
T3N1M0 |
M |
45 |
|
Mucinous Adenocarcinoma |
2 |
III |
T3N1M0 |
M |
42 |
|
Adenocarcinoma |
1 |
II |
T2N1M0 |
M |
77 |
|
Adenocarcinoma |
2 |
III |
T2N1M0 |
M |
66 |
|
Adenocarcinoma |
2 |
III |
T3NxM0 |
M |
61 |
|
Adenocarcinoma |
2 |
IIIA |
T2N1M0 |
M |
38 |
|
Adenocarcinoma |
3 |
IIIA |
T2N1M0 |
M |
68 |
|
Adenocarcinoma |
3 |
IIIA |
T2N1M0 |
M |
50 |
|
Mucinous Adenocarcinoma |
1 |
IIIA |
T2N1M0 |
F |
73 |
|
Mucinous Adenocarcinoma |
1 |
IIIB |
T3N1M0 |
M |
55 |
|
Adenocarcinoma |
n/a |
IIIB |
T3N1M0 |
M |
54 |
|
Adenocarcinoma |
1 |
n/a |
T4N2M0 |
M |
66 |
|
Adenocarcinoma |
2 |
n/a |
T4N3M0 |
M |
35 |
|
Mucinous Adenocarcinoma |
n/a |
IV |
T3N1M1 |
M |
26 |
|
Eosinophynic Granuloma |
n/a |
n/a |
n/a |
M |
25 |
|
Adenocarcinoma |
2 |
II |
T3N0Mx |
M |
79 |
|
Multipolyposis |
n/a |
n/a |
n/a |
M |
40 |
|
Lymphoma |
n/a |
n/a |
n/a |
M |
44 |
|
non-Hodgkin Lymphoma |
n/a |
n/a |
n/a |
M |
46 |
|
Leiomyosarcoma |
2 |
I |
T2N0M0 |
M |
65 |
|
non-Hodgkin Lymphoma |
1 |
IIIB |
T3N1M0 |
M |
79 |
|
Adenocarcinoma |
1 |
I |
T2N0M0 |
F |
38 |
|
Adenocarcinoma |
2 |
n/a |
T2N0M0 |
F |
57 |
|
Adenocarcinoma |
1 |
II |
T3N0M0 |
F |
46 |
|
Adenocarcinoma |
n/a |
II |
T2N0M0 |
F |
67 |
|
Adenocarcinoma |
3 |
III |
T4N3M0 |
M |
43 |
|
Adenocarcinoma |
2 |
III |
T3NxM0 |
F |
63 |
|
Adenocarcinoma |
2 |
III |
T3N1M0 |
F |
59 |
|
Mucinous Adenocarcinoma |
1 |
III |
T3N1M0 |
F |
53 |
|
Adenocarcinoma |
2 |
IIIA |
T2N1M0 |
F |
74 |
|
Adenocarcinoma |
1 |
IIIA |
T2N1M0 |
F |
66 |
|
Adenocarcinoma |
1 |
IIIB |
T3N1M0 |
F |
43 |
|
Mucinous Adenocarcinoma |
1 |
IIIB |
T3N1M0 |
F |
46 |
|
Adenocarcinoma |
3 |
IV |
T3NxM1 |
F |
70 |
|
Adenocarcinoma |
n/a |
IV |
n/a |
F |
69 |
|
Adenocarcinoma |
n/a |
IV |
T3N1M0 |
F |
58 |
|
non-Hodgkin Lymphoma |
n/a |
IIIA |
T2N1M0 |
F |
32 |
|
Papillary Adenocarcinoma |
2 |
III |
T3N0M0 |
F |
56 |
|
Papillary Adenocarcinoma |
n/a |
III |
T3NxM0 |
F |
63 |
References:
Saclarides TJ, Szeluga D, Staren ED: Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience. Dis Colon Rectum 37 (7): 635-42, 1994.